AlphaYouMS
Insider selling
Matthew Shields sold $532K of Teva Pharmaceutical Industries Ltd (TEVA) stock
Matthew Shields, EVP, Global Operations of Teva Pharmaceutical Industries Ltd (TEVA), sold 16,195 shares of TEVA stock worth $532K, per an SEC Form 4 filed Jun 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 3, 2026, 1 day before it was made public.
TEVA has moved +22.0% since the trade date, from $32.83 to $40.06 (Sep 21, 2026 close).
- Traded
- Jun 3, 2026
- Disclosed
- Jun 4, 2026
- Filing delay
- 1 day
- Price since
- +22.0%
- Role
- EVP, Global Operations
- Source
- SEC Form 4
More TEVA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.